Ionis Pharmaceuticals, Inc. IONS 深 沪
已收盘 08-07 16:00:00 美东时间
56.56
+2.070
+3.80%
华盛通- 最 高56.60
- 今 开54.73
- 成交量 200.93万股
- 最 低 54.40
- 昨 收 54.49
- 总市值 93.99亿
- 52周最高 86.74
- 市盈率 静 --
- 换手率 1.21%
- 52周最低 41.705
- 委 比 97.59%
- 总股本 1.66亿
- 历史最高 86.74
- 量 比 0.76
- 振 幅 4.04%
- 历史最低 6.25
- 每 手 1
- 风险率 11.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Praxis Precision Medicines reported progress on its CNS pipeline, including successful mid-cycle meetings for ulixacaltamide HCl and relutrigine with no major safety concerns from the FDA, and PDUFA dates set for January 2027 and December 2026, respectively. The company also completed FDA BIMO inspections without Form 483 observations. Commercial preparations are advancing for both programs. Additionally, Praxis received a Breakthrough Therapy De...
08-06 12:00
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
McCormick, Wabtec, Ecolab, Ionis, Fastenal Insider Shock
Insiders have been trading these 5 stocks: (($MKC)), (($WAB)), (($ECL)), (($ION...
08-01 21:01
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) stock plunged on Thursday after the company lowered its fiscal 2026 guidance. The company reported second-quarter adjusted earnings of $1.84 per share, beating the consensus of $1.55. Sales jumped 67% year over year to $1.291 billion, missing the consensus ...
07-31 02:37
Cytokinetics wins U.K. nod, NICE endorsement for heart drug
Cytokinetics (CYTK) announced on Thursday that the U.K. drug regulator approved its heart disease medication, Myqorzo (aficamten), and concurrently, the country’s health spending watchdog, the Nationa...
07-30 20:50
Microsoft To Rally More Than 40%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays cut the price target for Meta Platforms Inc (NASDAQ:META) from $830 to $780. Barclays analyst Ross Sa...
07-30 20:15
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $115
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $125 to $115.
07-30 18:38
财报速睇 | Ionis Pharmaceuticals, Inc. 2026财年Q2营收2.68亿美元，同比下降40.7%；归母净利润亏损1.15亿美元，由盈转亏
华盛资讯7月30日讯，Ionis Pharmaceuticals, Inc.公布2026财年Q2业绩，公司Q2营收2.68亿美元，同比下降40.7%，归母净利润亏损1.15亿美元，由盈转亏。
07-30 05:19
Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio
Biogen Inc. (NASDAQ:BIIB) stock is trading higher on Wednesday after the company reported second-quarter adjusted earnings of $3.60 per share, beating the consensus of $2.96. Revenue Tops Expectations On Growth Across Key Products The Alzheimer’s drug maker reported revenues of $2.736 billion, beati...
07-30 01:36
